MD2852C2 - Utilizarea budesonidei pentru tratamentul ascitei rezistente la pacienţii cu ciroză hepatică - Google Patents
Utilizarea budesonidei pentru tratamentul ascitei rezistente la pacienţii cu ciroză hepatică Download PDFInfo
- Publication number
- MD2852C2 MD2852C2 MDA20050089A MD20050089A MD2852C2 MD 2852 C2 MD2852 C2 MD 2852C2 MD A20050089 A MDA20050089 A MD A20050089A MD 20050089 A MD20050089 A MD 20050089A MD 2852 C2 MD2852 C2 MD 2852C2
- Authority
- MD
- Moldova
- Prior art keywords
- budesonide
- treatment
- hepatic cirrhosis
- pacients
- resistant ascites
- Prior art date
Links
- 206010003445 Ascites Diseases 0.000 title abstract 3
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 title abstract 2
- 229960004436 budesonide Drugs 0.000 title abstract 2
- 208000019425 cirrhosis of liver Diseases 0.000 title abstract 2
- 210000000683 abdominal cavity Anatomy 0.000 abstract 1
- 238000009825 accumulation Methods 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000006020 chronic inflammation Effects 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 210000003200 peritoneal cavity Anatomy 0.000 abstract 1
- 230000035699 permeability Effects 0.000 abstract 1
- 230000002792 vascular Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Invenţia se referă la medicină, în special la hepatologie.Esenţa invenţiei constă în utilizarea budesonidei pentru tratamentul ascitei rezistente la pacienţii cu ciroză hepatică decompensată.Rezultatul invenţiei constă în diminuarea procesului regional inflamator cronic prin micşorarea permeabilităţii peretelui vascular şi a transsudării lichidului în spaţiul interstiţial al organelor cavităţii abdominale şi preîntâmpină acumularea lui în cavitatea peritoneală, care duce la formarea ascitei rezistente.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20050089A MD2852C2 (ro) | 2005-03-28 | 2005-03-28 | Utilizarea budesonidei pentru tratamentul ascitei rezistente la pacienţii cu ciroză hepatică |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20050089A MD2852C2 (ro) | 2005-03-28 | 2005-03-28 | Utilizarea budesonidei pentru tratamentul ascitei rezistente la pacienţii cu ciroză hepatică |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD2852B1 MD2852B1 (ro) | 2005-09-30 |
| MD2852C2 true MD2852C2 (ro) | 2006-04-30 |
Family
ID=35057532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDA20050089A MD2852C2 (ro) | 2005-03-28 | 2005-03-28 | Utilizarea budesonidei pentru tratamentul ascitei rezistente la pacienţii cu ciroză hepatică |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD2852C2 (ro) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19742612A1 (de) * | 1997-09-26 | 1999-04-01 | Falk Pharma Gmbh | Budesonid zur Behandlung von cholestatischen Lebererkrankungen |
| WO1999039699A1 (en) * | 1998-02-09 | 1999-08-12 | Rtp Pharma, Inc. | Treatment of chronic inflammatory disorders of the gastrointestinal tract |
-
2005
- 2005-03-28 MD MDA20050089A patent/MD2852C2/ro not_active IP Right Cessation
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19742612A1 (de) * | 1997-09-26 | 1999-04-01 | Falk Pharma Gmbh | Budesonid zur Behandlung von cholestatischen Lebererkrankungen |
| WO1999039699A1 (en) * | 1998-02-09 | 1999-08-12 | Rtp Pharma, Inc. | Treatment of chronic inflammatory disorders of the gastrointestinal tract |
Non-Patent Citations (1)
| Title |
|---|
| Spencer C., Mc. Tavish D. Budesonide. A review of its pharmacological properties and therapeutic efficacy in inflammatory bowel disease. Drugs, 1995, vol. 50, p. 854-872 * |
Also Published As
| Publication number | Publication date |
|---|---|
| MD2852B1 (ro) | 2005-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR25C1043I1 (fr) | Utilisation de citrate ferrique dans le traitement de patients atteints d'une maladie rénale chronique | |
| EP2760371A4 (en) | VENTRICULAR TRANSCATHETER RECONSTRUCTION STRUCTURES, METHODS AND SYSTEMS FOR THE TREATMENT OF CONGESTIVE HEART FAILURE AND OTHER SUFFERING | |
| TR201818927T4 (tr) | Kataterlerde İyileştirme | |
| SG11201504463SA (en) | Combination double-barreled and debranching stent grafts | |
| EP3687394A4 (en) | CATHETER POSITIONING IN PEDIATRIC PATIENTS | |
| PH12018502593A1 (en) | Combinations of linagliptin and metformin | |
| MX2015013944A (es) | Inhibidor de quinasa. | |
| EP1662965A4 (en) | FORMULATIONS AND METHOD FOR THE TREATMENT OF BREAST CANCER WITH MORINDA CITRIFOLIA AND METHYLSULFONYLMETHANE | |
| WO2013022567A3 (en) | Vascular filter | |
| EP2182978A4 (en) | TISSUE KALLIKREIN FOR THE TREATMENT OF DISEASES ASSOCIATED WITH AMYLOID PROTEIN | |
| FR3005564B1 (fr) | Instrument destine a etre utlise pour modifier le volume de l'estomac d'un patient. | |
| EP2148675A4 (en) | ANTI-CANCER FOR THE DIAGNOSIS AND TREATMENT OF CANCER | |
| FR2919060B1 (fr) | Procede de dosage de l'ezrine pour le diagnostic in vitro du cancer colorectal. | |
| EP4279925A3 (en) | Dulaglutide for the treatment of chronic kidney disease | |
| JP2010209101A5 (ro) | ||
| MX2015001508A (es) | El uso de antitrombina en la oxigenacion por membrana extracorporea. | |
| EP2185162A4 (en) | POLYMER THERAPY FOR THE TREATMENT OF CHRONIC MICROVASCULAR DISEASES | |
| WO2007023154A3 (de) | EISEN(III)-KOMPLEXVERBINDtMGEN ZUR BEHANDLUNG VON EISENMANGEL-ZUSTÄNDEN BEI PATIENTEN MIT CHRONISCH-ENTZÜNDLICHER DARMERKRANKUNG | |
| de Franciscis et al. | Matrix metalloproteinases and endothelial dysfunction: the search for new prognostic markers and for new therapeutic targets for vascular wall imbalance | |
| EP2170351A4 (en) | METHOD AND COMPOSITION FOR TREATING CANCER AND OTHER ANGIOGENESIS-MEDIATED ILLNESSES | |
| EP2470217A4 (en) | OBJECT TO PAX2 FOR THE TREATMENT OF BREAST CANCER | |
| EP2455079A4 (en) | COMPOSITION FOR THE PREVENTION OR TREATMENT OF BONE DISEASES WITH COLFORSINE DAROPATE | |
| EP1889618A4 (en) | Combined drug for treating diabetes | |
| MD2852B1 (ro) | Utilizarea budesonidei pentru tratamentul ascitei rezistente la pacientii cu ciroza hepatica | |
| EP2136820A4 (en) | TARGET FOR BREAST CANCER THERAPY AND / OR DIAGNOSIS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
| MM4A | Patent for invention definitely lapsed due to non-payment of fees |